Clinical Trials on Estrogen-receptor Positive Invasive Metastatic Breast Cancer in United Kingdom
Total 1374 results
-
University of LouisvilleJames Graham Brown Cancer CenterRecruitingMetastatic Breast CancerUnited States
-
Minerva Biotechnologies CorporationCity of Hope Medical CenterRecruitingMetastatic Breast CancerUnited States
-
Rush University Medical CenterTerminatedMetastatic Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterMedImmune LLCCompletedMetastatic Breast CancerUnited States
-
University of Maryland, BaltimoreGenentech, Inc.TerminatedMetastatic Breast CancerUnited States
-
Abramson Cancer Center of the University of PennsylvaniaTerminatedMETASTATIC BREAST CANCERUnited States
-
Baylor Research InstituteCompletedMetastatic Breast CancerUnited States
-
University of Wisconsin, MadisonNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.TerminatedMetastatic Breast CancerUnited States
-
University of Alabama at BirminghamGenentech, Inc.CompletedMetastatic Breast CancerUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
Milton S. Hershey Medical CenterAvon FoundationCompletedMetastatic Breast CancerUnited States
-
Weill Medical College of Cornell UniversityBristol-Myers SquibbCompletedMetastatic Breast CancerUnited States
-
Western Regional Medical CenterTerminated
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; AstraZeneca; Brigham and Women's HospitalCompletedMetastatic Breast CancerUnited States
-
M.D. Anderson Cancer CenterCTI BioPharmaCompletedBreast Cancer | Metastatic Breast CancerUnited States
-
AgennixCompleted
-
Cancer Research NetworkHoffmann-La RocheCompletedMetastatic Breast CancerUnited States
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Brigham and Women's HospitalCompletedBreast Cancer | Metastatic Breast CancerUnited States
-
Yale UniversityGenentech, Inc.CompletedHer2-Positive Breast CancerUnited States
-
Columbia UniversityNational Cancer Institute (NCI); Acetylon Pharmaceuticals IncorporatedCompletedMetastatic Breast Cancer | Breast CarcinomaUnited States
-
Yale UniversityFoundation MedicineCompleted
-
Dartmouth-Hitchcock Medical CenterTerminated
-
University of Michigan Rogel Cancer CenterAventis Pharmaceuticals; Rhone-Poulenc RorerCompletedMetastatic Breast CancerUnited States
-
Dartmouth-Hitchcock Medical CenterHoffmann-La RocheCompletedMetastatic Breast CancerUnited States
-
University of Michigan Rogel Cancer CenterTerminated
-
R-PharmCompletedMetastatic Breast CancerItaly, United Kingdom, United States, France, Spain
-
Memorial Sloan Kettering Cancer CenterContext Therapeutics Inc.WithdrawnMetastatic Breast Cancer | Unresectable Breast CancerUnited States
-
National Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast CancerUnited States, Japan
-
Washington University School of MedicineBiovicaNot yet recruitingMetastatic Breast Cancer | Unresectable Breast CancerUnited States
-
Sarah Sammons, MDDaiichi SankyoRecruitingBreast Cancer | Breast Cancer Female | Metastatic Triple-Negative Breast Carcinoma | HER2-negative Breast Cancer | HER2 Negative Breast Carcinoma | ER-negative Breast Cancer | ER Positive Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast Cancer | Metastatic Breast Cancer | ER+ Breast Cancer | Metastatic Breast Carcinoma | HER2+ Breast Cancer | Oligometastatic Breast CarcinomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteHorizon Pharma Ireland, Ltd., Dublin IrelandCompletedBreast Cancer | Breast Cancer, Male | HER2-positive Breast Cancer | Breast Cancer FemaleUnited States
-
Medical College of WisconsinLoyola University ChicagoRecruitingMetastatic Breast CancerUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Foundation MedicineActive, not recruitingMetastatic Breast CancerUnited States
-
Joseph Baar, MD, PhDCompletedBreast Cancer | Metastatic Breast CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteVaccinex Inc.RecruitingHER2-positive Breast CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteImmunoRestorationRecruitingHER2-positive Breast CancerUnited States
-
University of Alabama at BirminghamRecruitingHER2-positive Breast CancerUnited States
-
Case Comprehensive Cancer CenterSuspendedHR-positive Breast CancerUnited States
-
University of WashingtonActive, not recruitingHER2-positive Breast CancerUnited States
-
Medical College of WisconsinCompletedNode Positive Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterDuke UniversityCompleted
-
University of Kansas Medical CenterTerminatedMetastatic Breast CancerUnited States
-
Western Regional Medical CenterTerminated
-
University of WashingtonNational Cancer Institute (NCI)CompletedStage IV Breast Cancer | Leptomeningeal Metastases | Recurrent Breast Cancer | Central Nervous System Metastases | Tumors Metastatic to BrainUnited States
-
Dartmouth-Hitchcock Medical CenterRecruitingBreast Cancer | ER Positive Breast CancerUnited States
-
Dana-Farber Cancer InstituteMyriad Genetics, Inc.Active, not recruitingBreast Cancer | Invasive Breast Cancer | Genetic Testing | in Situ Breast CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)WithdrawnHER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast CancerUnited States
-
Abramson Cancer Center at Penn MedicineActive, not recruitingAdvanced Breast Cancer | Metastatic Breast Cancer | BRCA1 Mutation | BRCA2 Mutation | Locally Advanced Breast CancerUnited States
-
AVEO Pharmaceuticals, Inc.CompletedMetastatic Breast CancerUnited States, Germany